Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Blood vessels grown from stem cells

12 April 2010

By Charlie McDermott

Appeared in BioNews 553
Stem cell-derived blood vessels grown in the lab could replace artificial versions currently used in heart bypass surgery, following a recent animal study.

Today, up to 40 per cent of patients are treated with artificial blood vessels. But these can become clogged within one to three years, which leads to infection, and do not behave like real blood vessels; never contracting or responding to changes in blood pressure, according to Dr Stephen E. McIlhenny, lead author of the study and tissue engineer of Thomas Jefferson University Hospital in Philadelphia.

Dr McIlhenny's team developed a less synthetic alternative, which they tested on rabbits. They extracted stem cells from the rabbits' fat tissue and encouraged them to differentiate into arterial cells, which were injected onto a protein scaffold.

'The significant finding is that we can build a blood vessel from donor tissue and an animal's own adult stem cells. Potentially, patients requiring bypass surgery could receive optimised grafts that would reduce their future complications', said Dr McIlhenny at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology annual conference in San Francisco.

The team's research involved 10 rabbits; five had blood vessels engineered from their own stem cells grafted into their aorta, to simulate a bypass procedure, and five had just the protein scaffold. Eight weeks later the protein scaffold group had developed evidence of blood clots and thickening of the vessel wall, as seen in human heart disease, compared to the stem cell-derived vessel group which had significantly less problems, reported Dr McIlhenny.

'Our grafts have the potential to be used for peripheral artery disease bypass (mostly in the legs), and arteriovenous fistula (a type of vascular access for hemodialysis), and heart bypass surgery. However, the first uses of the grafts would be for treatment of peripheral artery disease and dialysis access grafting', said Dr. McIlhenny.

Professor Chris Mason, chair of regenerative medicine bioprocessing at University College London, said: 'Whilst very early in the development of this alternative artery, none-the-less, if it proves successful, it could be a life-saving addition to the 'spare parts kit' for the cardiac surgeons of the future'.

This preliminary data is limited and Dr McIlhenny plans further testing on a larger animals, probably dogs, leading up to human trials in about three years.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

29 June 2015 - by Dr James Heather 
The NHS has announced that it plans to begin testing laboratory-produced blood in healthy volunteers by 2017...
05 December 2011 - by Dr Louisa Petchey 
Research in mice has shown the heart contains its own renewable source of stem cells which can differentiate into a variety of cell types. The research team in Australia hopes that one day the stem cells could be activated so a broken heart can be made to mend itself....
31 October 2011 - by Oliver Timmis 
Artificial blood, manufactured from human stem cells, could be used in patient trials within two years. The blood will be based on the universal donor group (O rhesus negative), a blood type suitable for up to 98 percent of the population...
19 September 2011 - by Dr Zara Mahmoud 
Scientists have identified 29 regions of the genome associated with hypertension in people of European origin. Of these, 16 areas contained completely new genes, which had not been previously associated with the risk of developing high blood pressure....
18 April 2011 - by Dr Rosie Gilchrist 
Scientists at Edinburgh University have grown kidney structures in the laboratory in a step they hope will lead to organs being grown for transplant patients from their own stem cells...

22 March 2010 - by Dr Vivienne Raper 
A UK child has become the world's first to receive a full windpipe transplant using an organ built from his own stem cells...
23 January 2010 - by Dr Rachael Panizzo 
Scientists at the University of California San Diego (UCSD), US, have developed a technique to transfer modified genes known to cause disease in humans into human embryonic stem cell (ES cell) lines. The modified ES cells behave like diseased cells and can be used to study human genetic diseases in the laboratory. The new technique provides an alternative approach to mouse 'knock out' models of disease....
14 December 2009 - by Dr Marianne Kennedy 
New research offers promise of restoring vision in patients with congenital or acquired corneal scarring. The findings were presented at the 49th Annual Meeting of the American Society of Cell Biology in San Diego, US....

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation